Ian Clements - 24 Nov 2021 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role: Chief Financial Officer
Signature: /s/ Jody Howe, Attorney-in-Fact
Issuer symbol: MIRM
Transactions as of: 24 Nov 2021
Net transactions value: +$20,505
Form type: 4
Filing time: 29 Nov 2021, 20:49:30 UTC
Previous filing: 15 Nov 2021
Next filing: 07 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MIRM	Common Stock	Purchase	$10,080	+700	+4.1%	$14.40	17,811	24 Nov 2021	Direct	F1
transaction	MIRM	Common Stock	Purchase	$10,425	+750	+4.2%	$13.90	18,561	26 Nov 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person's purchases of MIRM common stock reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's sale of 1,574 shares of MIRM common stock on October 1, 2021 at a price of $19.256. The transactions resulted in short-swing profits of $7,416.20 which the Reporting Person has disgorged to MIRM in accordance with Section 16(b) of the Securities Exchange Act of 1934.

Content

The Reporting Person's purchases of MIRM common stock reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's sale of 1,574 shares of MIRM common stock on October 1, 2021 at a price of $19.256. The transactions resulted in short-swing profits of $7,416.20 which the Reporting Person has disgorged to MIRM in accordance with Section 16(b) of the Securities Exchange Act of 1934.